Ascend Sport Technology to the Swiss Stock Exchange

Ascend Sport Technology points to the Swiss Merger Exchange with Evonext, already listed Valuation: 500 million francs Expected closure by the end of the year Company
Context
TL;DR
- Ascend Sport Technology Aims at Swiss Stock Exchange
- Merger with Evonext, already listed
- Valuation: CHF 500 million
- Expected closure by the end of the year
Key facts
- Company → Ascend Sport Technology
- Headquarters → Kriens (LU)
- Partner → Evonext, already listed
- Operation → Merger and new share issue
- Valuation → 500 million francs
- Evonext shares → 2.50 francs
- Expected deadline → by the end of the year
Ascend Sport Technology, a Lucerne company based in Kriens (LU), is preparing to land on the Swiss stock exchange. The path passes through a merger with Evonext, an already listed holding company. The parties have signed a binding union agreement; the merger is expected to close by the end of the year, but shareholders of both companies have yet to give their consent.
Ascend operates in the sector of new technologies applied to professional sports. The company focuses its activity on digital advertising, artificial intelligence and the commercial valorisation of sporting events. His interlocutor is the holders of sporting rights: clubs, leagues and competition organisers. The indicated objective is to increase commercial revenues.
The service is explained with a case related to football. During a match, Ascend can virtually replace pitchside advertising in broadcasts, allowing you to display different advertising messages in different countries. The described mechanism allows messages to be differentiated between one country and another.
The role of Evonext
Evonext is based in Reinach (BL) and is what remains of the previous biotech group Evolva. The holding is already listed and, through the merger, Ascend can access the stock exchange without a classic initial placement. The listing is therefore not described as a separate operation, but as the result of the union between the two companies.
The operation gives Ascend a value of 500 million francs and sets the price of Evonext shares at 2.50 francs; a share issue is also planned to raise new capital for the further growth of the company. In this way, access to the grant is linked to finding resources for the future development of Ascend.
The calendar has already gone through two steps. In August Evonext confirmed talks with Ascend. It also warned at the end of September that if the merger failed and no alternatives emerged, it could be liquidated. Now the binding agreement brings the decision to the shareholders of both companies.
For those who follow the Swiss economy, the news concerns a company based in Switzerland, with offices indicated in Kriens (LU) and Reinach (BL), and access to the stock exchange built through a merger. To orient yourself among the entrepreneurial realities of the country, you can also consult the aziende che assumono.
Operational details
The practical point of the matter is to distinguish what has already been signed from what remains subject to the vote. The combination agreement is binding, but the merger is expected to close by the end of the year and shareholders of both companies still need to approve it. For those who observe the Swiss stock market, the decisive step is therefore the completion of the union, not just the announcement.
The second element is structure. Ascend does not access the exchange through a classic initial placement; the entry point indicated by the source is Evonext, an already listed holding company. The new share issue runs in parallel and serves to raise capital for further growth. Merger, access to the stock exchange and raising of new capital are therefore linked in the same operation, although they remain different concepts.
| Element | Operation data |
|---|---|
| Access to the exchange | Merger with Evonext, without classic initial placement |
| Evaluation | Ascend: 500 million francs |
| Evonext Shares | 2.50 francs |
| Capital | New share issue for further growth |
Read the numbers without confusing them
The valuation of 500 million francs concerns Ascend in the transaction. The price of 2.50 francs instead concerns Evonext shares. They are two different indications: the first number is the valuation of the company involved in the merger, the second is the price indicated for the shares of the already listed holding. The source does not use the Evonext price to calculate a unit price of Ascend.
The before-after comparison must be limited to what the text allows to verify. Before the conclusion, Ascend is the technology company seeking access to the stock market through the merger; after the expected conclusion, the deal should give her that access and accompany it with a new issue. The raising is described as capital intended for further growth of the company.
The conditioned scenario
If the shareholders of both companies give their consent, the indicated timetable leads to completion by the end of the year. In this scenario, Ascend uses the merger to access the stock exchange and the concurrent issuance to raise capital. If consensus does not arrive and the merger fails, the source recalls Evonext's warning: in the absence of alternatives, the company could have been liquidated. The practical data to follow is therefore double: the shareholder vote and the closing of the operation.
The price and valuation are expressed in francs; for a separate currency comparison, the reader can use the comparatore CHF/EUR, without substituting it for reading the terms of the merger.
Useful tools to protect your net income
To reduce FX leakage, compare CHF-EUR exchange options and banks for cross-border workers.
Key points
To follow the story in an orderly manner, the reader can transform the advert into a control card. The sequence remains anchored to the steps described for Ascend and Evonext and separates the data already announced from the conditions still open.
Five checks
1. Identify the operation: It is a merger between Ascend and Evonext that allows access to the stock exchange without a classic initial placement. 2. Separate the companies: Ascend is based in Kriens (LU); Evonext is based in Reinach (BL) and is what remains of the previous biotech group Evolva. 3. Indicate the valuation of Ascend, equal to 500 million francs, and the price of 2.50 francs for Evonext shares. 4. Check the condition: Shareholders of both companies still need to give their consent to the transaction. 5. Monitor the outcome: The merger is expected to close by the end of the year and includes a planned share issue to raise new capital for further growth.
The first check serves to avoid treating what the source describes as a merger with an already listed holding company as a classic initial placement. The second separates Ascend, a technological company applied to professional sports, from Evonext, the listed company involved in the union. The third avoids mistaking Ascend's valuation for the price indicated for Evonext shares.
The procedure described by the announcement focuses on shareholder consent and the timing of the deal. Until that consensus arrives, closing by the end of the year remains a prediction. If the green light arrives, the reader can verify the two indicated results: Ascend's access to the stock exchange and the raising of capital through the new issue.
If the merger fails and there are no alternatives, the source recalls the scenario indicated by Evonext at the end of September: the company could have been liquidated. This step must be kept separate from Ascend's activity, which the source describes through digital advertising, artificial intelligence and commercial valorization services of sporting events.
To connect your focus on corporate economics to your personal picture, use the calcolatore stipendio e imposte.
Source: swissinfo.ch
Frequently Asked Questions
- What does Ascend Sport Technology do?
- It is a Lucerne-based company based in Kriens (LU) that is active in new technologies applied to professional sport. Its business includes digital advertising, artificial intelligence and commercial enhancement of sports events. Ascend helps clubs, leagues and competition organisers, i.e. sports rights holders, to increase commercial revenues. In a football match, it can virtually replace pitchside advertising in broadcasts and show different messages in different countries.
- Why does the merger bring Ascend to the stock market?
- Ascend merges with Evonext, an already listed holding company. According to the source, this structure allows Ascend to access the stock exchange without a classic initial placement. The merger agreement is binding, but the merger is expected to close by the end of the year and the shareholders of both companies have yet to give consent.
- What economic values are indicated?
- As part of the merger, Ascend is valued at CHF 500 million. Evonext shares are priced at CHF 2.50. The source also indicates a simultaneous share issue to raise new capital for the further growth of the company. The two amounts do not describe the same thing: one is Ascend's valuation in the transaction, the other is the Evonext share price.
- What happens if the merger fails?
- At the end of September, Evonext had warned that, in the event of the failure of the merger and in the absence of alternatives, it could be liquidated. The text does not present the liquidation as an outcome already decided, but as a possibility linked to the failure of the operation and the absence of alternatives. The closure also remains subject to the consent of the shareholders of both companies.